Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can we predict sudden cardiac death?

T Meinertz1, T Hofmann, M Zehender

  • 1Department of Cardiology, St George Hospital, Hamburg, Federal Republic of Germany.

Drugs
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodality assessment of aortic valve area in aortic stenosis: a multicenter validation study.

The international journal of cardiovascular imaging·2025
Same author

Recent taxonomic discoveries suggest a host-symbiont co-migration of <i>Russula</i> subsect. <i>Castanopsidum</i> with <i>Fagaceae</i> in the Americas.

Fungal systematics and evolution·2025
Same author

Electron Glass Phase with Resilient Zhang-Rice Singlets in LiCu_{3}O_{3}.

Physical review letters·2024
Same author

Considerations for the development of guidance on dose level selection for developmental and reproductive toxicity studies.

Regulatory toxicology and pharmacology : RTP·2024
Same author

Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection.

Antimicrobial agents and chemotherapy·2023
Same author

Microwave graph analogs for the voltage drop in three-terminal devices with orthogonal, unitary, and symplectic symmetry.

Physical review. E·2022
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Identifying patients at risk of sudden cardiac death (SCD) is challenging, with current methods identifying only 30-40%. Advanced investigations are crucial for high-risk individuals, including those with cardiomyopathy or coronary artery disease.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Electrophysiology

Background:

  • Sudden cardiac death (SCD) remains a significant concern, with limited ability to predict events in asymptomatic individuals.
  • Traditional risk factors like hypertension and high cholesterol have low predictive value for SCD in the general population.
  • Certain conditions, including hypertrophic cardiomyopathy, dilated cardiomyopathy, and coronary artery disease, are associated with increased SCD risk.

Purpose of the Study:

  • To review current methods for identifying patients at risk of sudden cardiac death.
  • To highlight key risk factors and diagnostic tools for various cardiac conditions.
  • To stratify patients into low, medium, and high risk categories for SCD.

Main Methods:

  • Review of existing literature on risk factors and predictive markers for sudden cardiac death.

Related Experiment Videos

  • Analysis of diagnostic approaches for asymptomatic individuals, patients with cardiomyopathies, and those with coronary artery disease.
  • Evaluation of electrocardiography (ECG), Holter monitoring, signal-averaged ECG, and electrophysiological testing.

    • Main Results:

    • Abnormal resting or exercise ECGs, familial history, and lifestyle factors are recognized risk factors but have low predictive value.
    • In hypertrophic cardiomyopathy, risk factors include family history, syncope, and age; ventricular tachycardia on Holter monitoring indicates higher risk.
    • In dilated cardiomyopathy, frequent ventricular arrhythmias and reduced ejection fraction predict SCD risk.
    • Coronary artery disease patients at risk are identified through coronary anatomy, ventricular function, ischemia, late potentials, arrhythmias, and electrophysiological testing results, allowing risk stratification.

    Conclusions:

    • Accurate prediction of sudden cardiac death remains a clinical challenge, necessitating a multi-faceted approach.
    • Risk stratification for sudden cardiac death is possible in specific patient groups, particularly those with underlying cardiac disease.
    • Further research and refined diagnostic strategies are needed to improve the identification and prevention of sudden cardiac death.